24/7 Biotech Cybersecurity Monitoring: Is EDR Enough?
Installing EDR does not give a biotech company 24/7 security. It gives the company the ability to detect suspicious activity. Those are not the same thing. That distinction gets uncomfortable for smaller biotech companies because many have made legitimate investments in endpoint protection, cloud security, identity controls, email security, vulnerability management, and logging. The technology […]
24/7 Threat Monitoring for Biotech: 7 Security Tests for CISOs
The 2:17 A.M. Test: 7 Things Every Biotech CISO Should Prove About Threat Monitoring Your biotech does not have 24/7 threat monitoring simply because your security technology operates 24/7. That may sound obvious. Operationally, it is one of the most important distinctions a CISO can make. Security tools do not sleep. People do. That creates […]
24/7 Biotech Cybersecurity: Managed Security & SOC Services
Your Biotech Doesn’t Need More Alerts. It Needs Someone Accountable at 2 A.M. Why 24/7 Security Is an Operating Decision, Not a Staffing Wish There is a sentence we hear constantly in growing organizations: “Our internal IT team handles security.” That statement may be technically correct. It can also conceal enormous risk. The issue is […]
Biotech Cybersecurity: 24/7 Security Monitoring & Threat Response
The Firewall Saw the Attack. The Business Didn’t. What the Enzo Biochem Breach Teaches Biotech Leaders About 24/7 Security The most important lesson from the Enzo Biochem ransomware attack is not that ransomware is dangerous. Every CISO already knows that. The lesson is much more uncomfortable: Security technology can identify suspicious activity while the business […]
Biotech Cybersecurity: 24/7 Security Monitoring & Response
Your Biotech Company Has Security Tools. Investors Want Proof Someone Will Respond The most dangerous cybersecurity assumption in biotech is that security technology running 24/7 creates 24/7 protection. It does not. An endpoint platform can generate an alert at 2:13 a.m. A SIEM can correlate suspicious activity. A cloud platform can record a privileged login […]
Biotech Cybersecurity Due Diligence: Protect Your Valuation
The Cyber Due Diligence Question That Can Damage a Biotech Valuation Biotech leaders often assume cyber due diligence is a documentation exercise: provide the policies, list the tools, confirm backups exist, and move forward. That belief is dangerously incomplete. Serious investors, strategic partners, insurers, and acquiring companies are not only asking what controls exist. They […]
Your SIEM Is Working. Your Security Operating Model Is Not.
Biotech leaders often assume that buying a SIEM, adding endpoint protection, and assigning alerts to the internal IT team creates a functioning security operation. It does not. It’s not even close to meeting the minimum threshold. It creates visibility. Visibility matters, but visibility without dedicated investigation, response authority, and after-hours coverage only tells you that […]
24×7 Security Accountability Without 24×7 Capacity Is an Executive Decision
Many biotech executives believe their internal IT team “owns security,” so the company is covered. That sounds responsible, it even sounds like a logical argument. However, in most cases…it is the opposite. Ownership without staffing, funding, response authority, and around-the-clock operating capacity is not a security strategy. It is an executive expectation placed on a […]
Commercialization Will Expose the Security Operations You Never Built
The most dangerous cybersecurity assumption in a pre-commercial biotech company is that security operations can mature later after the next funding round, regulatory milestone, or first revenue. That thinking is backward. Commercialization does not create cyber risk. It exposes security debt accumulated while the business was moving quickly. The identities, cloud platforms, research systems, contractors, […]
Security Alerts Alone Will Not Protect Your Biotech Business
Alerts Are Not Protection If No One Can Explain the Risk Security alerts can make an organization feel protected. That feeling can be misleading. A biotech firm may have endpoint alerts, firewall logs, email warnings, cloud notifications, failed login reports, and vulnerability findings moving through the environment every day. To an executive, that may sound […]